It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: ignorant_ape
a reply to: neoholographic
the likley hood - of a universal " coronaviruses " vaccine is minute - ts a large family - and we are already seing mutations in N19COVID
so what would they have studied ?
originally posted by: ketsuko
a reply to: neoholographic
This isn't about Obama. This is about understanding that we stopped researching gain of function on diseases we had no effective treatment for because we nearly had those bugs escape on us, more than once!
What part of we almost let these bugs out of our own labs around 5 years ago don't you get? That's why this was all stopped.
Scientists for Science are confident that biomedical research on potentially dangerous pathogens can be performed safely and is essential for a comprehensive understanding of microbial disease pathogenesis, prevention and treatment. The results of such research are often unanticipated and accrue over time; therefore, risk-benefit analyses are difficult to assess accurately.
If we expect to continue to improve our understanding of how microorganisms cause disease we cannot avoid working with potentially dangerous pathogens. In recognition of this need, significant resources have been invested globally to build and operate BSL-3 and BSL-4 facilities, and to mitigate risk in a variety of ways, involving regulatory requirements, facility engineering and training. Ensuring that these facilities operate safely and are staffed effectively so that risk is minimized is our most important line of defense, as opposed to limiting the types of experiments that are done.
originally posted by: neoholographic
Scientist warned about the coronavirus in 2015 and said we need vaccines in case of a pandemic. You will not here about this in the media, but the Obama administration cut funding that would have allowed researh into vaccines for the coronavirus in 2015. Here's the paper.
President Obama has proposed a $50-million cut to a federal immunization program, citing diminished need for government-funded vaccinations thanks to the Affordable Care Act.
. Rather than drawing a sharp bright line between GOFR studies that are ethically acceptable and those that are ethically unacceptable, this framework is designed to indicate where any given study would fall on an ethical spectrum—where imaginable cases of GOFR might range from those that are most ethically acceptable (perhaps even ethically praiseworthy or ethically obligatory), at one end of the spectrum, to those that are most ethically problematic or unacceptable (and thus should not be funded, or conducted), at the other. The aim should be that any GOFR pursued (and/or funded) should be as far as possible towards the former end of the spectrum.
The Obama administration cut and in some cases stopped funding to programs that would have given us a vaccine for coronavirus.
Because the deliberative process launching today will aim to address key questions about the risks and benefits of gain-of-function studies, during the period of deliberation, the U.S. Government will institute a pause on funding for any new studies that include certain gain-of-function experiments involving influenza, SARS, and MERS viruses. Specifically, the funding pause will apply to gain-of-function research projects that may be reasonably anticipated to confer attributes to influenza, MERS, or SARS viruses such that the virus would have enhanced pathogenicity and/or transmissibility in mammals via the respiratory route.
During this pause, the U.S. Government will not fund any new projects involving these experiments and encourages those currently conducting this type of work – whether federally funded or not – to voluntarily pause their research while risks and benefits are being reassessed. The funding pause will not apply to the characterization or testing of naturally occurring influenza, MERS, and SARS viruses unless there is a reasonable expectation that these tests would increase transmissibility or pathogenicity.
Scientist warned about the coronavirus in 2015 and said we need vaccines in case of a pandemic.
Scientists for Science are confident that biomedical research on potentially dangerous pathogens can be performed safely and is essential for a comprehensive understanding of microbial disease pathogenesis, prevention and treatment. The results of such research are often unanticipated and accrue over time; therefore, risk-benefit analyses are difficult to assess accurately.
If we expect to continue to improve our understanding of how microorganisms cause disease we cannot avoid working with potentially dangerous pathogens. In recognition of this need, significant resources have been invested globally to build and operate BSL-3 and BSL-4 facilities, and to mitigate risk in a variety of ways, involving regulatory requirements, facility engineering and training. Ensuring that these facilities operate safely and are staffed effectively so that risk is minimized is our most important line of defense, as opposed to limiting the types of experiments that are done.
No he wasn't. He was talking about coronaviruses that originate from bats and are genetically similar.